Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by lscfaon Feb 18, 2023 4:56pm
152 Views
Post# 35293921

RE:RE:Drops.6 cents What now ?

RE:RE:Drops.6 cents What now ?

Damn fins are out of date too. They were filed Jan 17/23 but failed to disclose in a subsequent events section a 3rd tranche of convertible notes. Total is $1,300,000 US => 7,647,059 Shs
 



Dec 14/22 early warning report 
In addition, on November 1, 2022, the Issuer issued, to Meridian Holdings II, on a private placement basis, a senior convertible note (the “Note”) for an aggregate principal amount of up to US$1,600,000 and bearing interest at a rate of 12% per annum (or 16% in the event of a default). An initial amount of US$400,000 was funded by Meridian Holdings II on November 1, 2022, and an additional US$500,000 and US$400,000 was funded on November 18, 2022 and December 9, 2022, respectively. The principal amount outstanding under the Note is convertible into Common Shares at a price of US$0.17 (C$0.23) and any accrued and unpaid interest is convertible into Common Shares at the last closing price (in US dollars) of the Common Shares on the TSX-V on the day prior to the issuance of a news release announcing such conversion

<< Previous
Bullboard Posts
Next >>